Furthermore, brivaracetam, a novel antiepileptic drug (AED) with higher SV2A affinity than levetiracetam[34], shows higher potency in several preclinical models of epilepsy[35] and is currently in clinical development[36]. Here, SV2A is linked to epilepsy.